Phase 2 study of MEDI-575, an anti-platelet-derived growth factor-α antibody, inpatients with recurrent glioblastoma

Authors
Category Primary study
JournalNeuro-Oncology
Year 2015
This article has no abstract
Epistemonikos ID: 79b3dbb78ac48cd1a953f54c78c9e8c63c14880b
First added on: Feb 07, 2025